Suppr超能文献

肝纤维化与多种心血管代谢疾病风险因素相关:弗雷明汉心脏研究。

Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.

机构信息

Section of GastroenterologyBoston Medical CenterBoston University School of MedicineBostonMA.

Department of BiostatisticsBoston UniversityBostonMA.

出版信息

Hepatology. 2021 Feb;73(2):548-559. doi: 10.1002/hep.31608. Epub 2021 Feb 6.

Abstract

BACKGROUND AND AIMS

NAFLD is increasing in prevalence and will soon be the most common chronic liver disease. Liver stiffness, as assessed by vibration-controlled transient elastography (VCTE), correlates with hepatic fibrosis, an important predictor of liver-related and all-cause mortality. Although liver fat is associated with cardiovascular risk factors, the association between hepatic fibrosis and cardiovascular risk factors is less clear.

APPROACH AND RESULTS

We performed VCTE, assessing controlled attenuation parameter (CAP; measure of steatosis) and liver stiffness measurement (LSM) in 3,276 Framingham Heart Study adult participants (53.9% women, mean age 54.3 ± 9.1 years) presenting for a routine study visit. We performed multivariable-adjusted logistic regression models to determine the association between LSM and obesity-related, vascular-related, glucose-related, and cholesterol-related cardiovascular risk factors. The prevalence of hepatic steatosis (CAP ≥ 290 dB/m) was 28.8%, and 8.8% had hepatic fibrosis (LSM ≥ 8.2 kPa). Hepatic fibrosis was associated with multiple cardiovascular risk factors, including increased odds of obesity (OR, 1.82; 95% CI, 1.35-2.47), metabolic syndrome (OR, 1.49; 95% CI 1.10-2.01), diabetes (OR, 2.67; 95% CI, 1.21-3.75), hypertension (OR, 1.52; 95% CI, 1.15-1.99), and low high-density lipoprotein cholesterol (OR, 1.47; 95% CI, 1.09-1.98), after adjustment for age, sex, smoking status, alcohol drinks/week, physical activity index, aminotransferases, and CAP.

CONCLUSIONS

In our community-based cohort, VCTE-defined hepatic fibrosis was associated with multiple cardiovascular risk factors, including obesity, metabolic syndrome, diabetes, hypertension, and high-density lipoprotein cholesterol, even after accounting for covariates and CAP. Additional longitudinal studies are needed to determine if hepatic fibrosis contributes to incident cardiovascular disease risk factors or events.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)的发病率正在上升,很快将成为最常见的慢性肝病。通过振动控制瞬时弹性成像(VCTE)评估的肝硬度与肝纤维化相关,后者是肝脏相关和全因死亡率的重要预测因素。尽管肝脏脂肪与心血管危险因素相关,但肝纤维化与心血管危险因素之间的关联尚不清楚。

方法与结果

我们对 3276 名弗雷明汉心脏研究成年参与者(53.9%为女性,平均年龄 54.3±9.1 岁)进行了 VCTE 检查,评估了受控衰减参数(CAP;衡量脂肪变性的指标)和肝硬度测量(LSM)。我们进行了多变量调整的逻辑回归模型,以确定 LSM 与肥胖相关、血管相关、葡萄糖相关和胆固醇相关心血管危险因素之间的关联。肝脏脂肪变性(CAP≥290dB/m)的患病率为 28.8%,8.8%的人患有肝纤维化(LSM≥8.2kPa)。肝纤维化与多种心血管危险因素相关,包括肥胖的几率增加(OR,1.82;95%CI,1.35-2.47)、代谢综合征(OR,1.49;95%CI,1.10-2.01)、糖尿病(OR,2.67;95%CI,1.21-3.75)、高血压(OR,1.52;95%CI,1.15-1.99)和低高密度脂蛋白胆固醇(OR,1.47;95%CI,1.09-1.98),调整年龄、性别、吸烟状况、每周饮酒量、身体活动指数、氨基转移酶和 CAP 后。

结论

在我们的社区为基础的队列中,VCTE 定义的肝纤维化与多种心血管危险因素相关,包括肥胖、代谢综合征、糖尿病、高血压和高密度脂蛋白胆固醇,即使在考虑了协变量和 CAP 后也是如此。需要进一步的纵向研究来确定肝纤维化是否会导致心血管疾病的发生风险因素或事件。

相似文献

引用本文的文献

3
Decoding the Liver-Heart Axis in Cardiometabolic Diseases.解读心脏代谢疾病中的肝心轴
Circ Res. 2025 May 23;136(11):1335-1362. doi: 10.1161/CIRCRESAHA.125.325492. Epub 2025 May 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验